Pila Pharma Ab Stock Net Income
| PILA Stock | 1.21 0.02 1.68% |
As of the 6th of February, Pila Pharma holds the Variance of 36.88, risk adjusted performance of (0.08), and Coefficient Of Variation of (858.32). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pila Pharma, as well as the relationship between them.
Analyzing historical trends in various income statement and balance sheet accounts from Pila Pharma's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Pila Pharma's valuation are summarized below:Pila Pharma AB does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Pila |
Pila Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pila Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pila Pharma.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Pila Pharma on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Pila Pharma AB or generate 0.0% return on investment in Pila Pharma over 90 days. Pila Pharma is related to or competes with NextCell Pharma, Biovica International, Sprint Bioscience, Nanologica, Spago Nanomedical, Alligator Bioscience, and Oncozenge. More
Pila Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pila Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pila Pharma AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 51.16 | |||
| Value At Risk | (6.98) | |||
| Potential Upside | 5.53 |
Pila Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pila Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pila Pharma's standard deviation. In reality, there are many statistical measures that can use Pila Pharma historical prices to predict the future Pila Pharma's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.69) | |||
| Total Risk Alpha | (1.00) | |||
| Treynor Ratio | 1.1 |
Pila Pharma February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | 1.11 | |||
| Mean Deviation | 3.62 | |||
| Coefficient Of Variation | (858.32) | |||
| Standard Deviation | 6.07 | |||
| Variance | 36.88 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.69) | |||
| Total Risk Alpha | (1.00) | |||
| Treynor Ratio | 1.1 | |||
| Maximum Drawdown | 51.16 | |||
| Value At Risk | (6.98) | |||
| Potential Upside | 5.53 | |||
| Skewness | (2.83) | |||
| Kurtosis | 18.18 |
Pila Pharma AB Backtested Returns
Pila Pharma AB maintains Sharpe Ratio (i.e., Efficiency) of -0.15, which implies the firm had a -0.15 % return per unit of risk over the last 3 months. Pila Pharma AB exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pila Pharma's Variance of 36.88, coefficient of variation of (858.32), and Risk Adjusted Performance of (0.08) to confirm the risk estimate we provide. The company holds a Beta of -0.65, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Pila Pharma are expected to decrease at a much lower rate. During the bear market, Pila Pharma is likely to outperform the market. At this point, Pila Pharma AB has a negative expected return of -0.97%. Please make sure to check Pila Pharma's total risk alpha, maximum drawdown, skewness, as well as the relationship between the treynor ratio and potential upside , to decide if Pila Pharma AB performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.24 |
Weak predictability
Pila Pharma AB has weak predictability. Overlapping area represents the amount of predictability between Pila Pharma time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pila Pharma AB price movement. The serial correlation of 0.24 indicates that over 24.0% of current Pila Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.24 | |
| Spearman Rank Test | 0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 0.17 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Pila Pharma AB reported net income of (17.21 Million). This is 105.04% lower than that of the Healthcare sector and 124.57% lower than that of the Biotechnology industry. The net income for all Sweden stocks is 103.01% higher than that of the company.
Pila Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pila Pharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pila Pharma could also be used in its relative valuation, which is a method of valuing Pila Pharma by comparing valuation metrics of similar companies.Pila Pharma is currently under evaluation in net income category among its peers.
Pila Fundamentals
| Return On Equity | -1.3 | |||
| Return On Asset | -0.27 | |||
| Operating Margin | (4.58) % | |||
| Current Valuation | 48.17 M | |||
| Shares Outstanding | 18.41 M | |||
| Shares Owned By Insiders | 43.03 % | |||
| Price To Book | 7.07 X | |||
| Price To Sales | 25.21 X | |||
| Revenue | 719.23 K | |||
| Gross Profit | 680.94 K | |||
| EBITDA | (17.16 M) | |||
| Net Income | (17.21 M) | |||
| Book Value Per Share | 0.47 X | |||
| Cash Flow From Operations | (9.36 M) | |||
| Earnings Per Share | (1.72) X | |||
| Target Price | 7.32 | |||
| Market Capitalization | 50.44 M | |||
| Total Asset | 31.81 M | |||
| Net Asset | 31.81 M |
About Pila Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pila Pharma AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pila Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pila Pharma AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pila Stock Analysis
When running Pila Pharma's price analysis, check to measure Pila Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pila Pharma is operating at the current time. Most of Pila Pharma's value examination focuses on studying past and present price action to predict the probability of Pila Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pila Pharma's price. Additionally, you may evaluate how the addition of Pila Pharma to your portfolios can decrease your overall portfolio volatility.